HCV INFECTION IN HBSAG POSITIVE CHRONIC LIVER-DISEASE

被引:0
|
作者
FATUZZO, F
MUGHINI, MT
CACOPARDO, B
LAROSA, R
NIGRO, L
LUPO, G
BRUNO, S
ZUCCARELLO, M
CALTABIANO, E
ZIPPER, F
COSENTINO, S
RUSSO, R
NUNNARI, A
机构
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of anti-HCV antibodies was determined for a group of 68 patients with various forms of chronic liver disease. All patients that were anti-HCV positive but did not show signs of HBV replication had severe liver disease. We therefore suggest that HCV may be responsible for liver damage in HBsAg positive subjects when there are no evident signs of HBV replication.
引用
收藏
页码:325 / 326
页数:2
相关论文
共 50 条
  • [41] PREVALENCE OF DELTA ANTIBODIES AMONG URBAN HBSAG-POSITIVE CHRONIC LIVER-DISEASE PATIENTS IN EGYPT
    ELZAYADI, A
    PONZETTO, A
    SELIM, O
    FORZANI, B
    LAVARINI, C
    RIZZETTO, M
    HEPATO-GASTROENTEROLOGY, 1988, 35 (06) : 313 - 315
  • [42] ADENINE-ARABINOSIDE THERAPY IN HBSAG-POSITIVE CHRONIC LIVER-DISEASE - A CONTROLLED-STUDY
    BASSENDINE, MF
    CHADWICK, RG
    SALMERON, J
    SHIPTON, U
    THOMAS, HC
    SHERLOCK, S
    GASTROENTEROLOGY, 1981, 80 (05) : 1016 - 1022
  • [43] UNEXPECTED SERIOUS LIVER-DISEASE IN YOUNG ASYMPTOMATIC HBSAG POSITIVE HEMOPHILIACS
    FISHER, SE
    SPERO, JA
    LEWIS, JH
    VANTHIEL, DH
    GASTROENTEROLOGY, 1978, 75 (05) : 964 - 964
  • [44] TOXIC NEUROPATHY AFTER ADENINE-ARABINOSIDE TREATMENT IN CHRONIC HBSAG-POSITIVE LIVER-DISEASE
    KANTEREWICZ, E
    BRUGUERA, M
    VIOLA, C
    LAMARCA, J
    RODES, J
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1990, 12 (01) : 90 - 92
  • [45] INTERFERON SYSTEM AND NATURAL-KILLER CELL-ACTIVITY IN HBSAG POSITIVE CHRONIC LIVER-DISEASE
    KATO, Y
    NAKAGAWA, H
    KOBAYASHI, K
    HATTORI, N
    GASTROENTEROLOGY, 1980, 79 (05) : 1030 - 1030
  • [46] HIGH-FREQUENCY OF HBEAG-MINUS CHRONIC HBSAG-POSITIVE LIVER-DISEASE IN EGYPT
    ELZAYADI, A
    SOBER, M
    LAVANCHY, D
    HASSEEB, N
    SELIM, O
    MAYERAT, C
    DABBOUS, H
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 3 (04): : 178 - 183
  • [47] NORMAL LYMPHOCYTE INTERFERON-PRODUCTION IN ADULT HBSAG-POSITIVE CHRONIC ACTIVE LIVER-DISEASE
    PONZETTO, A
    ZUCCA, M
    MARCUCCI, F
    RIZZETTO, M
    ACTIS, GC
    BONINO, F
    GIOANNINI, P
    JOURNAL OF MEDICAL VIROLOGY, 1979, 4 (01) : 43 - 50
  • [48] RELATIONSHIP BETWEEN THE SEVERITY OF THE LIVER-DISEASE AND EPIDEMIOLOGIC AND VIROLOGICAL FEATURES IN PATIENTS WITH CHRONIC HCV INFECTION
    MARCELLIN, P
    MARTINOT, M
    KILANI, A
    DUCHATELLE, V
    GOURNAY, J
    RANDRIANATOAVINA, I
    LEBRETON, V
    DEGOTT, C
    BENHAMOU, JP
    ERLINGER, S
    HEPATOLOGY, 1995, 22 (04) : 667 - 667
  • [49] DIFFERENT MECHANISMS OF LYMPHOCYTE-MEDIATED LIVER-CELL DAMAGE IN AUTOIMMUNE AND HBSAG POSITIVE CHRONIC LIVER-DISEASE
    MIELIVERGANI, G
    VERGANI, D
    PORTMANN, B
    MURRAYLYON, I
    THOMPSON, R
    WOOLF, I
    EDDLESTON, ALWF
    WILLIAMS, R
    GUT, 1981, 22 (05) : A422 - A422
  • [50] THE LOCALIZATION OF HCV AND THE EXPRESSION OF FAS ANTIGEN IN THE LIVER OF HCV-RELATED CHRONIC LIVER-DISEASE
    OHISHI, M
    SAKISAKA, S
    KOGA, H
    SASATOMI, K
    KOJI, T
    NAKANE, PK
    NOGUCHI, K
    SATA, M
    TANIKAWA, K
    HEPATOLOGY, 1995, 22 (04) : 672 - 672